Sama Rinda's Form 4 filing
Axonics, Inc. (AXNX) · filed Feb 2, 2023
- Accession no.
- 0001562180-23-000876
- Filed
- Feb 2, 2023
- Trade date
- Jan 31-Feb 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.13M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sama RindaCIK 0001756399 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | AGrant or awardAcquired | +8,750 | $0.00 | $0 | 63,408 | Direct | |
| Jan 31, 2023 | Common Stock | MOption exerciseAcquired | +30,875 | $0.00 | $0 | 94,283 | Direct | |
| Jan 31, 2023 | Common Stock | SSaleDisposed | −7,791 | $61.17 | −$476,575.47 | 86,492 | Direct | |
| Jan 31, 2023 | Common Stock | SSaleDisposed | −5,634 | $61.12 | −$344,350.08 | 80,858 | Direct | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −741 | $60.43 | −$44,778.63 | 80,117 | Direct | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −4,334 | $61.02 | −$264,460.68 | 75,783 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | AGrant or awardAcquired | +17,500 | $0.00 | $0 | 17,500 | Direct | |
| Jan 31, 2023 | Common Stock | AGrant or awardAcquired | +8,750 | $0.00 | $0 | 8,750 | Direct | |
| Jan 31, 2023 | Common Stock | MOption exerciseDisposed | −10,875 | $0.00 | $0 | 0 | Direct | |
| Jan 31, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.